These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23033474)

  • 1. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.
    Lin L; Tan B; Pantapalangkoor P; Ho T; Baquir B; Tomaras A; Montgomery JI; Reilly U; Barbacci EG; Hujer K; Bonomo RA; Fernandez L; Hancock RE; Adams MD; French SW; Buslon VS; Spellberg B
    mBio; 2012; 3(5):. PubMed ID: 23033474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
    Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure- and Ligand-Dynamics-Based Design of Novel Antibiotics Targeting Lipid A Enzymes LpxC and LpxH in Gram-Negative Bacteria.
    Zhou P; Hong J
    Acc Chem Res; 2021 Apr; 54(7):1623-1634. PubMed ID: 33720682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.
    Huang W; Yao Y; Long Q; Yang X; Sun W; Liu C; Jin X; Li Y; Chu X; Chen B; Ma Y
    PLoS One; 2014; 9(6):e100727. PubMed ID: 24956279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors.
    Titecat M; Liang X; Lee CJ; Charlet A; Hocquet D; Lambert T; Pagès JM; Courcol R; Sebbane F; Toone EJ; Zhou P; Lemaitre N
    J Antimicrob Chemother; 2016 Oct; 71(10):2874-82. PubMed ID: 27330072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance.
    Breslow JM; Meissler JJ; Hartzell RR; Spence PB; Truant A; Gaughan J; Eisenstein TK
    Infect Immun; 2011 Aug; 79(8):3317-27. PubMed ID: 21576323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an Acinetobacter baumannii lptD Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis.
    Bojkovic J; Richie DL; Six DA; Rath CM; Sawyer WS; Hu Q; Dean CR
    J Bacteriol; 2015 Dec; 198(4):731-41. PubMed ID: 26668262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
    Moffatt JH; Harper M; Harrison P; Hale JD; Vinogradov E; Seemann T; Henry R; Crane B; St Michael F; Cox AD; Adler B; Nation RL; Li J; Boyce JD
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4971-7. PubMed ID: 20855724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.
    García-Quintanilla M; Pulido MR; Pachón J; McConnell MJ
    PLoS One; 2014; 9(12):e114410. PubMed ID: 25485716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad-spectrum suppression of bacterial pneumonia by aminoglycoside-propagated Acinetobacter baumannii.
    Hood-Pishchany MI; Pham L; Wijers CD; Burns WJ; Boyd KL; Palmer LD; Skaar EP; Noto MJ
    PLoS Pathog; 2020 Mar; 16(3):e1008374. PubMed ID: 32168364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
    Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
    PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia.
    Knapp S; Wieland CW; Florquin S; Pantophlet R; Dijkshoorn L; Tshimbalanga N; Akira S; van der Poll T
    Am J Respir Crit Care Med; 2006 Jan; 173(1):122-9. PubMed ID: 16210672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.
    Nielsen TB; Pantapalangkoor P; Luna BM; Bruhn KW; Yan J; Dekitani K; Hsieh S; Yeshoua B; Pascual B; Vinogradov E; Hujer KM; Domitrovic TN; Bonomo RA; Russo TA; Lesczcyniecka M; Schneider T; Spellberg B
    J Infect Dis; 2017 Aug; 216(4):489-501. PubMed ID: 28931235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibody Therapy against
    Nielsen TB; Yan J; Slarve M; Lu P; Li R; Ruiz J; Lee B; Burk E; Talyansky Y; Oelschlaeger P; Hurth K; Win W; Luna BM; Bonomo RA; Spellberg B
    Infect Immun; 2021 Sep; 89(10):e0016221. PubMed ID: 34310884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
    García-Quintanilla M; Caro-Vega JM; Pulido MR; Moreno-Martínez P; Pachón J; McConnell MJ
    Antimicrob Agents Chemother; 2016 Aug; 60(8):5076-9. PubMed ID: 27270288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic murine models for Acinetobacter baumannii infection.
    Luo G; Spellberg B; Gebremariam T; Bolaris M; Lee H; Fu Y; French SW; Ibrahim AS
    J Antimicrob Chemother; 2012 Jun; 67(6):1439-45. PubMed ID: 22389456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blp1 protein shows virulence-associated features and elicits protective immunity to Acinetobacter baumannii infection.
    Skerniškytė J; Karazijaitė E; Deschamps J; Krasauskas R; Armalytė J; Briandet R; Sužiedėlienė E
    BMC Microbiol; 2019 Nov; 19(1):259. PubMed ID: 31752683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.